Association between choice of reversal agent for neuromuscular block and postoperative pulmonary complications in patients at increased risk undergoing non-emergency surgery: STIL-STRONGER, a multicentre matched cohort study
Douglas A. Colquhoun(School of the Art Institute of Chicago), Shital Vachhani(The University of Texas MD Anderson Cancer Center), Sarah Tingle(University of Arkansas for Medical Sciences), Alvin F. Stewart(University of Arkansas for Medical Sciences), Robert E. Freundlich(Vanderbilt University Medical Center), Robert M. Craft(University of Tennessee at Knoxville), Michael W. Sjoding(University of Michigan), Allison M. Janda(University of Michigan), Graciela Mentz(University of Michigan), Patrick J. McCormick(School of the Art Institute of Chicago), Michelle T. Vaughn(School of the Art Institute of Chicago), Michael R. Mathis(School of the Art Institute of Chicago), Rebecca A. Schroeder(Duke Medical Center), Lori D. Bash(School of the Art Institute of Chicago), Nirav Shah(School of the Art Institute of Chicago), Amir A. Ghaferi(Southwestern Medical Center), Sachin Kheterpal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Richard D. Urman(Brigham and Women's Hospital), Brad M. Taicher(Apple (Israel)), Robert B. Schonberger(Yale University), Bhiken I. Naik(University of Michigan), Joseph Ruiz(The University of Texas MD Anderson Cancer Center), Karen B. Domino(Neurological Surgery), Brandon M. Togioka(Oregon Health & Science University)
Cited by 36
Related Papers
The American Society of Anesthesiologists Postoperative Visual Loss Registry
|Anesthesiology|2006|403
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER)
|Anesthesiology|2020|302
Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn
|New England Journal of Medicine|2019|261